ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.96
0.71%
US Tech 100
20,762.73
1.73%
S&P 500
5,942.47
1.26%
US Dollar vs CAD
1.44457
0.00%
Bitcoin
98,400.00
0.30%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Jasper Therapeutics Inc (JSPR) Share Price

Jasper Therapeutics Inc

Jasper Therapeutics Inc (JSPR)

NASDAQ
19.27
-1.82
(-8.63%)
Closed January 04 3:00PM
Delayed by 15 minutes
19.28
0.01
(0.05%)
After Hours: 6:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
19.28
Bid
19.11
Ask
20.07
Volume
445,051
18.80 Day's Range 22.25
6.50 52 Week Range 31.01
Market Cap
289.226M
Previous Close
21.09
Open
21.49
Last Trade
50
@
20
Last Trade Time
Financial Volume
US$ 9,191,068
VWAP
20.6517
Average Volume (3m)
273,105
Shares Outstanding
15,001,353
Dividend Yield
-
PE Ratio
-4.49
Earnings Per Share (EPS)
-4.3
Revenue
-
Net Profit
-64.47M

About Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.jaspertherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPR. The last closing price for Jasper Therapeutics was US$21.09. Over the last year, Jasper Therapeutics shares have traded in a share price range of US$ 6.50 to US$ 31.01.

Jasper Therapeutics currently has 15,001,353 shares outstanding. The market capitalization of Jasper Therapeutics is US$316.38 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -4.49.

Ask ADVFN Intelligence (AI)

Jasper Therapeutics (JSPR) Options Flow Summary

JSPR Options Flow

Overall Flow

Bearish

Net Premium

-23k

Calls / Puts

50.00%

Buys / Sells

0.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

JSPR Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 13 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

March 05 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

March 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

February 09 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 06 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 02 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 04 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.28-14.539007092222.5622.98519.2726844221.31744278CS
4-3.76-16.319444444423.0423.8919.2719396921.63517077CS
124.5931.24574540514.6926.0514.619127310520.81279157CS
26-3.64-15.881326352522.9226.0514.4223302320.24579257CS
5212.614189.2289228926.66631.016.517321020.28999023CS
156-58.82-75.313700384178.181.223.86253324718.24959071CS
260-121.32-86.2873399716140.6188.83.86269659854.37376267CS

JSPR - Frequently Asked Questions (FAQ)

What is the current Jasper Therapeutics share price?
The current share price of Jasper Therapeutics is US$ 19.28
How many Jasper Therapeutics shares are in issue?
Jasper Therapeutics has 15,001,353 shares in issue
What is the market cap of Jasper Therapeutics?
The market capitalisation of Jasper Therapeutics is USD 316.38M
What is the 1 year trading range for Jasper Therapeutics share price?
Jasper Therapeutics has traded in the range of US$ 6.50 to US$ 31.01 during the past year
What is the PE ratio of Jasper Therapeutics?
The price to earnings ratio of Jasper Therapeutics is -4.49
What is the reporting currency for Jasper Therapeutics?
Jasper Therapeutics reports financial results in USD
What is the latest annual profit for Jasper Therapeutics?
The latest annual profit of Jasper Therapeutics is USD -64.47M
What is the registered address of Jasper Therapeutics?
The registered address for Jasper Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Jasper Therapeutics website address?
The website address for Jasper Therapeutics is www.jaspertherapeutics.com
Which industry sector does Jasper Therapeutics operate in?
Jasper Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

JSPR Discussion

View Posts
Monksdream Monksdream 2 months ago
JSPR under $20
👍️0
tw0122 tw0122 3 months ago
Rinse repeat back to $19 get out and play to $17
👍️0
tw0122 tw0122 3 months ago
$15.87 + 5% low floater 10m .Most missed the early run to $19 rinse repeat

08:22 AM EDT, 10/14/2024 (MT Newswires) -- Jasper Therapeutics (JSPR) said Monday that preliminary data from its phase 1b/2a study of briquilimab showed that 93% of the adult participants with cold urticaria or symptomatic dermographism in both dose groups showed a clinical response to the treatment within six weeks.

In the 120mg dose cohort, 83% of participants experienced a complete response, the company said, adding briquilimab was well tolerated with no serious adverse events.

Jasper said that it secured regulatory clearance to enroll a 180mg dose cohort for the study and expects to report full trial data in the first half of 2025.

Shares of Jasper were up more than 15% in recent Monday premarket activity.
👍️0
Monksdream Monksdream 4 months ago
JSPR in an uptrend
👍️0
ipo_dude ipo_dude 4 months ago
Lets go. On out way to 30
👍️0
Monksdream Monksdream 10 months ago
JSPR 10Q due March 7
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Nice thanks moving to $SUNW 52WL !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Looking good 90s is next thin !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
90s very soon !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Nice squeeze at this level will be nice !
Waiting
👍️0
FROZENFLAME FROZENFLAME 1 year ago
https://ir.jaspertherapeutics.com/news-releases/news-release-details/jasper-therapeutics-announces-ind-clearance-phase-1b2a-study
👍️0
FROZENFLAME FROZENFLAME 1 year ago
https://x.com/wkrbnews/status/1709554398584578412?s=46&t=SOfgYFcNY1OxgkraPxHd4g
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Pressure building up, let’s POP !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Let’s see some 90s and close the week strong !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Looking good !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Nice close !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
80s close will be great !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Bid and volume creeping up, we need to hit 80s and I think the rest will be history, sure we will find out .
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Nice healthy trading, next leg up should be coming soon, IMO .
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Should see some 80s tomorrow, IMO .
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Waiting !
$JSPR
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Very thin all the way to 80s !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Needs volume !
👍️0
FROZENFLAME FROZENFLAME 1 year ago
Interesting PPS !
👍️0
Jayzp Jayzp 2 years ago
jspr vs ther

Strong buy ther
Reddit stock news

https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html
👍️0
INFINITI INFINITI 2 years ago
Yes it can today is day one hold tight $$$$&
👍️0
dennisv dennisv 2 years ago
This Can Fly High!
👍️0
dennisv dennisv 2 years ago
55 Minutes To Go!
👍️0
INFINITI INFINITI 2 years ago
SQUEEZE EM to $3 let’s gooooo$$$
👍️0
Invest-in-America Invest-in-America 2 years ago
JSPR: Kick-ASS!!!!



👍️0
Triple nickle Triple nickle 2 years ago
Hmmmm 1.80
👍️0
INFINITI INFINITI 2 years ago
Looking good I’m in $$$$ let’s goooo
👍️0
makinezmoney makinezmoney 2 years ago
$JSPR: Just spiked there to $2.10


Boooooooommmmmmmmmmmmmmmmmm


GO $JSPR
👍️0
dennisv dennisv 2 years ago
This Could Fly Higher!
👍️0
dennisv dennisv 2 years ago
Stay Long!
https://www.americanbulls.com/m/SignalPage.aspx?lang=en&Ticker=JSPR
👍️0
TechandBio TechandBio 2 years ago
Bought on a whim at the open just sold.

Profits going back to core positions.

$JSPR
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Halt
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Halt. Is a stop to refuel eat rest. I guess its the same
👍️0
Welsh_Dragon Welsh_Dragon 2 years ago
How many is that 40+ today??
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Halt
👍️0
Welsh_Dragon Welsh_Dragon 2 years ago
So shady. Keeps the price in check, scares the traders into locking profit, allows the MM to cover into the un-halts. Very unfair.
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Halt
👍️0
Welsh_Dragon Welsh_Dragon 2 years ago
Going up to test HOD so prob another halt lol
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Halt
Insiders hilding the majority
👍️0
ZipCash ZipCash 2 years ago
Shaddy how they keeping holding it up
I am out already, unfortunately pps will drop back down because its only fast 1 and company is running out of funds, I can see insiders selling and some hedge funds.
Be back when its settled down
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
Wow halt 9
👍️0
ZipCash ZipCash 2 years ago
#ABVC next to run big just like $JSPR
👍️0
IOUBLOKE1 IOUBLOKE1 2 years ago
37 million OS
6.36 FLOAT
91% INSIDERS AND institutiins
212000 short
👍️0
hondaboost hondaboost 2 years ago
Shorts might be coming in to short it heavily, with so huge volumes.
👍️0
makinezmoney makinezmoney 2 years ago
$JSPR: FANTASTICCCCCCCCcccccccccccc runner


Now 3.40


I saw this in premarket at $1 but took my eye off of it cuz of other runners, but wow.


NICELY DONE.


JSPRW alsoooooooooo getting it done now



GO $JSPR
👍️0

Your Recent History

NASDAQ
JSPR
Jasper Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads